Plain-English translation of NCT05955105 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a combination of two medications: ILB2109 (taken as a tablet) and (given as an injection). Researchers want to find the right doses of these medications when used together, and then test how well they work against 10 different types of advanced cancer, including lung cancer, breast cancer, melanoma, and others.
Many people with advanced cancers have exhausted standard treatment options like chemotherapy or radiation. This trial is exploring whether combining these two newer drugs might offer hope to patients who no longer have effective standard therapies available.
You would visit the research clinic regularly for safety and effectiveness check-ups at pre-specified time points. You would take ILB2109 tablets by mouth and receive injections as part of the treatment schedule. Throughout the trial, doctors would monitor your blood work, heart function, and how your cancer is responding through imaging and blood tests to ensure the medications are working and are safe for you.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China